1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with mibefradil in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (mibefradil) | Trials (mibefradil) | Recent Studies (post-2010) (mibefradil) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 667 | 69 | 143 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bochkov, VN; Cheglakov, IB; Clozel, JP; Hahn, M; Tkachuk, VA | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and mibefradil
Article | Year |
---|---|
Blockade of receptor-operated calcium channels by mibefradil (Ro 40-5967): effects on intracellular calcium and platelet aggregation.
Topics: Benzimidazoles; Blood Platelets; Calcium; Calcium Channel Blockers; Egtazic Acid; Humans; Mibefradil; Platelet Activating Factor; Platelet Aggregation; Tetrahydronaphthalenes | 1995 |